FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/20530974

Download in:

View as

General Info

PMID
20530974